Navigation Links
BD Announces Results for Fourth Fiscal Quarter and Full Year
Date:11/4/2009

-------- -------- ---------- ---------- --------- BD MEDICAL ----------- Medical Surgical Systems $532,974 $509,301 4.6 9.3 (4.7) Diabetes Care 180,688 175,038 3.2 6.2 (3.0) Pharmaceutical Systems 272,548 226,285 20.4 27.1 (6.7) Ophthalmic Systems 19,288 18,972 1.7 6.2 (4.5) ------------- ------ ------ --- --- ---- TOTAL $1,005,498 $929,596 8.2 13.0 (4.8) ----- ---------- -------- --- ---- ---- BD DIAGNOSTICS -------------- Preanalytical Systems $294,625 $287,106 2.6 6.3 (3.7) Diagnostic Systems 285,384 265,960 7.3 9.5 (2.2) ------------- ------- ------- --- --- ---- TOTAL $580,009 $553,066 4.9 7.8 (2.9) ----- -------- -------- --- --- ---- BD BIOSCIENCES -------------- Cell Analysis $234,234 $253,602 (7.6) (6.0) (1.6) Discovery Labware 77,992 75,892 2.8 3.3 (0.5) ------------ ------ ------ --- --- ---- TOTAL $312,226 $329,494 (5.2) (3.8) (1.4) ----- -------- -------- ---- ---- ---- TOTAL REVENUES $1,897,733 $1,812,156 4.7 8.4 (3.7) -------------- ---------- ---------- --- --- ---- BECTON DICKINSON AND COMPANY SUPPLEMENTAL REVENUE INFORMATION REVENUES BY BUSINESS SEGMENTS AND UNITS Twelve Months Ended September 30, (Unaudited; Amounts in thousands)
'/>"/>
SOURCE BD (Becton, Dickinson and Company)
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., , WEST PALM BEACH, Fla., Nov. 25 /PRNe...earing impaired Americans, especially the 27 milli...ays may not be all that happy, says audiologist Ci...of HearUSA (Amex: EAR ), one of America,s largest...tudies have linked hearing loss to stress, frustra...
(Date:11/25/2009)..., , BASKING RIDGE, N.J., Nov. 25 /PRNewsw...ny leading the development of antithrombotic aptam...id Mazzo, PhD, CEO and President, will be presenti...nference at the New York Palace Hotel in New York ...:10pm (EST) on Tuesday, December 1 and will includ...
(Date:11/25/2009)..., , NEW YORK, Nov. 25 /PRNewswire/ -...earch report is available in its catalogue: ,, ...ive ,, http://www.reportlinker.com/p0164330/...e.html ,, Rising incidence of breast cancer in... principal factor influencing growth in the mammog...
Breaking Medicine Technology:For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 3Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Reportlinker Adds Mammography Equipment - A Global Market Perspective 8DATATRAK Signs 6 Year Study with New Device Client 5306 1DATATRAK Signs 6 Year Study with New Device Client 5306 2DATATRAK Signs 6 Year Study with New Device Client 5306 3Curemark Announces Senior Executive Promotions 5301 1Curemark Announces Senior Executive Promotions 5301 2Curemark Announces Senior Executive Promotions 5301 3Early Defibrillator After Heart Attack May Not Pay Off 59091 1Early Defibrillator After Heart Attack May Not Pay Off 59091 2Early Defibrillator After Heart Attack May Not Pay Off 59091 3
...tigational regimen yielded nearly double SVR rate ...eneration HCV protease inhibitor SCH 900518 presen...k, April 23 Schering-Plough Corporation (NYSE: ... SPRINT-1 study showed boceprevir, its investigati...nation with peginterferon alfa-2b and ribavirin, s...
... Continuing Education Online Activity and Podcast ...ril 22 Acute lymphoblastic leukemia (ALL) is a co...cant advances in the treatment of pediatric patien...ealthcare professionals who treat adult patients w... the multitude of factors affecting management opt...
Other Medicine Technology:Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 2Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 3Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 4Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 5Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 6Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 7Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 8Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 9Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 10Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 11Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients 12Expert Insights in Acute Lymphoblastic Leukemia: Current Challenges and Future Directions 2
(Date:11/29/2009)...The following is an investment opinion release iss... Intellivest Securities Research, Inc., ("ISR") a ...ed a Report on BioClinica, Inc. ( BIOC) which serv...and medical device industries. A primary service ...t medical imaging portions of their submissions re...
(Date:11/29/2009)...ads to more self-defensive finger pointing, study ...s) -- The blame game is a contagious one, a new st..., Researchers found that when people see someone b...nfair accusation, they,re much more likely to enga...rs protecting their egos, we become defensive, too...
(Date:11/28/2009)... Welcome to syngo® .plaza(1), the new...om Siemens Healthcare. As the first Picture Ar...emens where 2D, 3D, and 4D reading come together i... the way multimodality images are read today. Siem...entific Assembly and Annual Meeting of the Radiolo...
(Date:11/27/2009)...re-FirstCall/ -- GSI Group Inc. (Pink Sheets: GSIG...ogy products and semiconductor systems, today anno...eholders has been scheduled for Friday, April 30, ...e announced in due course. As previously announce...Stephen Bershad, a holder of greater than ten perc...
(Date:11/27/2009)...re-USNewswire/ -- Preventing disease is the goal o... year, new vaccines are being added to assist in d...ity for the same period of time? And, if not, when...unity strong? ,, In this month,s issue of Ped...diatrics, Michael Pichichero MD, Director of the R...
Breaking Medicine News(10 mins):Health News:Research Report on BioClinica, Inc. as Speculative Buy 2Health News:When Accusations Start to Fly, They Multiply 2Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 2Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 3Health News:GSI Group Calls Shareholders Meeting 2Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3
... Patients with rheumatoid arthritis hopes have bee...howed positive results and was safe without any si... Roche Holding AG will file the drug Actemra for r...4519.TO), which is controlled by Roche. Roche owns...
... Civilians in Indonesia's Aceh, which was wracked ...s of mental trauma that could trigger more violenc...e International Organisation for Migration and Har... 39 percent for anxiety. The report sampl...
... Animal rights activists strutted naked through To... boycott of fashion giant Burberry for using fur....p to the Burberry store on the Ginza strip of high...st by People for the Ethical Treatment of Animals,...
... The many Australians taking to the bottle is not ...ed a bottle neck in the health system, overburdene...n the people’s health. Binge drinking has b...the next 20 years. Many Australians will be suffer...
... One of Australia's biggest bread companies is not...brands of bread with folic acid. They are petition...is proposal. The objective of such a proposa... If you ask Ian Greenshields from Goodman Fiel...
... The suspended West Coast Eagles star Ben Cousins ...rents broke the news in March to confirm// that he...evealed that he was under treatment at an overseas...name of the drug that he had been using. Sub...
Other Medicine News:Health News:New Drug for Rheumatoid Arthritis Looks Promising. 2Health News:Indonesia's Acehnese Suffer High Rates of Mental Trauma 2Health News:Cousins Recovering from His Substance Abuse Problem 2
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
Medicine Products: